Table 5.
Association between serum 25(OH)D3 levels and NAFLD.
| Variable | NAFLD n (%) | Control n (%) | Univariate model | Adjusted model (OR (95%CI)) | ||
|---|---|---|---|---|---|---|
| Model 1 | Model 2 | Model 3 | ||||
| Serum 25(OH)D3 | ||||||
| <12 ng/mL | 51 (16.3) | 52 (17.0) | Reference | Reference | Reference | Reference |
| 12-20 ng/mL | 160 (51.1) | 130 (42.5) | 1.255 (0.800, 1.969) | 1.202 (0.763, 1.895) | 0.562, (0.084,3.778) | 0.154 (0.012,2.057) |
| >20 ng/mL | 102 (32.6) | 124 (40.5) | 0.839 (0.526, 1.338) | 0.740 (0.457, 1.198) | 0.076 (0.006, 1.037) | 0.019 (0.001, 0.619) |
| p trend | – | – | 0.075 | 0.035 | <0.001 | <0.001 |
Model 1: Adjusted for age, gender. Model 2: Adjusted for age, gender, body mass index (BMI), insulin (INS), glucose (GLU). Model 3: Adjusted for age, gender, body mass index (BMI), insulin (INS), glucose (GLU), alanine aminotransferase (ALT), γ-glutamyl transpeptidase (GGT), alkaline phosphatase (ALP).